Literature DB >> 25280405

Quercetin bioavailability is associated with inadequate plasma vitamin C status and greater plasma endotoxin in adults.

Yi Guo1, Eunice Mah2, Richard S Bruno3.   

Abstract

OBJECTIVE: Quercetin bioavailability exhibits high interindividual variation for reasons that remain unclear. We conducted a 24-h pharmacokinetic study to investigate whether individual differences in circulating antioxidants, oxidative stress and inflammation, and intestinal permeability affect quercetin bioavailability.
METHODS: Healthy adults (n = 9 M/7 F; 34.3 ± 4.5 y; 27.0 ± 1.7 kg/m(2)) ingested 1095 mg quercetin aglycone with a standardized meal. Plasma antioxidants, biomarkers of oxidative stress and inflammation, and endotoxin were measured at baseline (0 h), and quercetin and its methylated metabolites isorhamnetin and tamarixetin were measured at timed intervals for 24 h.
RESULTS: Plasma pharmacokinetics of quercetin, isorhamnetin and tamarixetin were highly variable between participants (CVinter = 37-96%). Plasma vitamin C concentrations (34.6 ± 2.5 μmol/L), but no other antioxidants, were inversely correlated to the Cmax and AUC0 to 24 h of total quercetin (Qtotal; sum of quercetin, isorhamnetin and tamarixetin; r = -0.52 to -0.53; P < 0.05). Plasma endotoxin (0.13 ± 0.01 EU/mL), a surrogate marker of intestinal permeability, was correlated to Qtotal Cmax (r = 0.45; P < 0.05) and tended to be correlated to Qtotal AUC0 to 24 h (r = 0.38; P = 0.07). Additionally, vitamin C was inversely related to C-reactive protein, myeloperoxidase, and endotoxin (r = -0.46 to -0.55; P < 0.05), whereas endotoxin was positively correlated to C-reactive protein (r = 0.73; P < 0.05).
CONCLUSIONS: These findings suggest that vitamin C status and plasma endotoxin may be associated with interindividual variations in quercetin bioavailability. Greater quercetin absorption and bioavailability may be associated with poor vitamin C status and increased intestinal permeability in healthy adults.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endotoxin; Interindividual variability; Pharmacokinetics; Quercetin; Vitamin C

Mesh:

Substances:

Year:  2014        PMID: 25280405     DOI: 10.1016/j.nut.2014.03.032

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  6 in total

1.  Therapeutic Potential of Flavonoids and Zinc in COVID-19.

Authors:  Harold E Landis; Bruk Getachew; Yousef Tizabi
Journal:  Medpress Nutr Food Sci       Date:  2021-12-31

Review 2.  Focus on the high therapeutic potentials of quercetin and its derivatives.

Authors:  Axelle Septembre-Malaterre; Ahcène Boumendjel; Anne-Laure Sandenon Seteyen; Chailas Boina; Philippe Gasque; Pascale Guiraud; Jimmy Sélambarom
Journal:  Phytomed Plus       Date:  2022-01-15

Review 3.  Isoquercetin as an Anti-Covid-19 Medication: A Potential to Realize.

Authors:  Majambu Mbikay; Michel Chrétien
Journal:  Front Pharmacol       Date:  2022-03-02       Impact factor: 5.810

Review 4.  The Anticancer Potential of Plant-Derived Nutraceuticals via the Modulation of Gene Expression.

Authors:  Maria Vrânceanu; Damiano Galimberti; Roxana Banc; Ovidiu Dragoş; Anamaria Cozma-Petruţ; Simona-Codruţa Hegheş; Oliviu Voştinaru; Magdalena Cuciureanu; Carmina Mariana Stroia; Doina Miere; Lorena Filip
Journal:  Plants (Basel)       Date:  2022-09-26

Review 5.  The relationship between vitamin C status, the gut-liver axis, and metabolic syndrome.

Authors:  Maret G Traber; Garry R Buettner; Richard S Bruno
Journal:  Redox Biol       Date:  2018-12-26       Impact factor: 11.799

Review 6.  Neurofibromatosis: Molecular Pathogenesis and Natural Compounds as Potential Treatments.

Authors:  Anusha Amaravathi; Janet L Oblinger; D Bradley Welling; A Douglas Kinghorn; Long-Sheng Chang
Journal:  Front Oncol       Date:  2021-09-17       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.